Skip to main content
. 2018 Nov 13;8:16727. doi: 10.1038/s41598-018-35067-2

Figure 3.

Figure 3

Serum concentrations of SELENOP and selenium at baseline in people with or without the development of glucose intolerance at follow up. We defined the onset of glucose intolerance by combining participants diagnosed with type 2 diabetes and those with impaired glucose tolerance. Data represent the means ± SD.